A

Amgen

Makes biotech medicines for serious illnesses

Global Trade Compliance Senior Manager

Financial Crime & AMLConfirmed live in the last 24 hours
Full-timeThousand Oaks, CA, USA

About the Job

Requirements

  • A doctorate degree and 2 years of experience in compliance or screening operations, risk management, regulatory affairs, audit, law, or a related field; or a master's degree and 4 years of such experience; or a bachelor's degree and 6 years of such experience; or an associate's degree and 10 years of such experience.
  • Experience as a trade compliance subject matter expert at a multinational company; healthcare or life sciences experience is preferred.
  • Strong knowledge of Bureau of Industry and Security and Office of Foreign Assets Control sanctions regulations, the 50 Percent Rule, and other global restricted-party screening requirements.
  • Experience conducting ownership due diligence and ultimate beneficial ownership investigations, including analysis of complex direct and indirect ownership structures.
  • Proficiency with sanctions and trade compliance platforms such as Dow Jones, Descartes, MK Denial, Sayari, Kharon, SAP GTS, Oracle GTM, or comparable systems.
  • Experience conducting and managing investigations, incident management, and remediation plans.
  • Ability to synthesize, analyze, and communicate complex compliance data and concepts to diverse audiences.
  • Ability to leverage artificial intelligence and advanced analytics for compliance monitoring, risk assessment, and data-driven decision-making.
  • Strong critical thinking, writing, negotiation, presentation, project management, and organizational skills.
  • Ability to think strategically, translate strategy into action plans, prioritize competing demands, resolve conflict, meet deadlines, and operate independently.
  • Demonstrated ability to build effective relationships across departments and geographies, influence all levels of staff and management, and work successfully in a global matrix.
  • High ethical standards, professional integrity, maturity, flexibility, and sensitivity to diverse groups and perspectives.

Responsibilities

  • Lead key elements of Amgen's global trade compliance program, providing strategic guidance across sanctions, export controls, restricted-party screening, clinical valuation, and other international trade compliance matters.
  • Own the enterprise framework for screening counterparties, transactions, and ownership structures under the U.S. Department of the Treasury's Office of Foreign Assets Control 50% rule, the U.S. Department of Commerce's Bureau of Industry and Security 50% rule, and other applicable global regulatory authorities.
  • Serve as the primary escalation point for high-risk screening alerts and complex ownership determinations; lead enhanced due diligence activities and prepare risk assessments and recommended operational actions while supporting worldwide business operations in partnership with legal, business partners, and cross-functional stakeholders.
  • Lead the global clinical trial customs valuation program, including maintaining valuation methodologies, coordinating the annual true-up process, and partnering with stakeholders to ensure compliance with applicable clinical customs valuation requirements.
  • Leverage automation, artificial intelligence, advanced analytics, and digital technologies to improve efficiency, scalability, and risk detection in the Global Trade Compliance program.
  • Support additional trade compliance initiatives and special projects as business priorities and global regulations evolve.
  • Provide trade compliance support for strategic business initiatives, acquisitions, product launches, supply chain changes, and other enterprise projects.
  • Lead multiple complex initiatives simultaneously in a dynamic global environment.
  • Foster a culture of ethics, integrity, accountability, and continuous improvement throughout the organization.

Desired Qualifications

  • Experience as a trade compliance subject matter expert at a multinational company; healthcare or life sciences experience is preferred.
  • Strong knowledge of Bureau of Industry and Security and Office of Foreign Assets Control sanctions regulations, the 50 Percent Rule, and other global restricted-party screening requirements.
  • Experience conducting ownership due diligence and ultimate beneficial ownership investigations, including analysis of complex direct and indirect ownership structures.
  • Proficiency with sanctions and trade compliance platforms such as Dow Jones, Descartes, MK Denial, Sayari, Kharon, SAP GTS, Oracle GTM, or comparable systems.
  • Experience conducting and managing investigations, incident management, and remediation plans.
  • Ability to synthesize, analyze, and communicate complex compliance data and concepts to diverse audiences.
  • Ability to leverage artificial intelligence and advanced analytics for compliance monitoring, risk assessment, and data-driven decision-making.
  • Strong critical thinking, writing, negotiation, presentation, project management, and organizational skills.
  • Ability to think strategically, translate strategy into action plans, prioritize competing demands, resolve conflict, meet deadlines, and operate independently.
  • Demonstrated ability to build effective relationships across departments and geographies, influence all levels of staff and management, and work successfully in a global matrix.
  • High ethical standards, professional integrity, maturity, flexibility, and sensitivity to diverse groups and perspectives.

About the Company

Amgen

Makes biotech medicines for serious illnesses

Amgen develops and makes biologic medicines, which are drugs built from proteins and antibodies grown in living cells, for serious conditions such as heart disease, cancer, and bone loss. Its anemia drug Epogen, approved in 1989, became one of the biotechnology industry's first blockbuster medicines. Amgen grows these drugs in large tanks called bioreactors, and its products include the cholesterol drug Repatha, the bone-building drug Evenity, and the severe asthma drug Tezspire. It earns money by selling these medicines, mostly through large drug wholesalers that supply hospitals and pharmacies. Amgen was founded in 1980 and is based in Thousand Oaks, California.

Company size
10,001+
Company stage
IPO
Headquarters
Thousand Oaks, CA
Founded
1980

Recently Posted Jobs

Explore more opportunities at Amgen

See more jobs